User menu

Genetic and acquired thrombotic factors in chronic hepatitis C.

Bibliographic reference Poujol-Robert, Armelle ; Rosmorduc, Olivier ; Serfaty, Lawrence ; Coulet, Florence ; Poupon, Raoul ; et. al. Genetic and acquired thrombotic factors in chronic hepatitis C.. In: The American journal of gastroenterology, Vol. 99, no. 3, p. 527-31 (2004)
Permanent URL http://hdl.handle.net/2078.1/25837
  1. Rappaport AM, Virchows Arch [Pathol Anat], 402, 107 (1983)
  2. Goodman ZD, Gastroenterology, 83, 786 (1982)
  3. Wanless IR, Hepatology, 21, 1238 (1995)
  4. Alison Malcolm, Golding Matthew, Lalani El-Nasir, Nagy Peter, Thorgeirsson Snorri, Sarraf Catherine, Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells, 10.1016/s0168-8278(97)80051-7
  5. Rosendaal FR, Venous thrombosis: a multicausal disease, 10.1016/s0140-6736(98)10266-0
  6. Rosenberg Robert D., Aird William C., Vascular-Bed–Specific Hemostasis and Hypercoagulable States, 10.1056/nejm199905203402007
  7. Koster T., Vandenbroucke J.P., Rosendaal F.R., Briët E., Rosendaal F.R., Blann A.D., Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis, 10.1016/s0140-6736(95)90166-3
  8. Rosendaal FR, Semin Hematol, 34, 171 (1997)
  9. Robert A, Thromb Haemost, 71, 220 (1994)
  10. Ridker Paul M., Hennekens Charles H., Lindpaintner Klaus, Stampfer Meir J., Eisenberg Paul R., Miletich Joseph P., Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men, 10.1056/nejm199504063321403
  11. Poort SR, Blood, 88, 3698 (1996)
  12. The French Metavir Cooperative Study Group, Hepatology, 20, 15 (1994)
  13. Nygard O, Am J Clin Nutr, 67, 263 (1998)
  14. Lowe G. D. O., Rumley A., Woodward M., Morrison C. E., Philippou H., Lane D. A., Tunstall-Pedoe H., EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE, 10.1046/j.1365-2141.1997.1222936.x
  15. Kelly DA, Semin Liver Dis, 7, 182 (1987)
  16. Tait RC, Thromb Haemost, 73, 87 (1995)
  17. Manzano M. L., Arocena C., Tomás J. F., Hedner U., Quiroga J. A., Carreño V., Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk : , 10.1097/00001721-200004001-00018
  18. Dumontier I, Gastroenterol Clin Biol, 16, 120 (1992)
  19. Kloczko J, Haemostasis, 22, 340 (1992)
  20. Green AJ, J Lab Clin Med, 83, 189 (1974)
  21. Maisonneuve P, J Clin Path, 30, 221 (1977)
  22. Castillo R., Maragall S., Rodés J., Clemente C., Profitós J., Ordinas A., Increased factor VIII complex and defective ristocetin-induced platelet aggregation in liver disease, 10.1016/0049-3848(77)90118-9
  23. Hankey Graeme J, Eikelboom John W, Homocysteine and vascular disease, 10.1016/s0140-6736(98)11058-9
  24. Malinow M.R., Nieto F.J., Kruger W.D., Duell P.B., Hess D.L., Gluckman R.A., Block P.C., Holzgang C.R., Anderson P.H., Seltzer D., Upson B., Lin Q.R., The Effects of Folic Acid Supplementation on Plasma Total Homocysteine Are Modulated by Multivitamin Use and Methylenetetrahydrofolate Reductase Genotypes, 10.1161/01.atv.17.6.1157
  25. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J.H., den Heijer M., Kluijtmans L.A.J., van den Heuve L.P., Rozen R., A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, 10.1038/ng0595-111
  26. Poynard Thierry, Ratziu Vlad, Charlotte Frédéric, Goodman Zachary, McHutchison John, Albrecht Janice, Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C, 10.1016/s0168-8278(00)00097-0
  27. Violi F, Thromb Haemost, 77, 44 (1997)